XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.3%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16356)	10/18/2003 10:27:35 PM
From: aknahow	Read Replies (1) of 17367

BPI may work bu so does other stuff. ODonoghue has been busy. 1: O'Donoghue GT, Pidgeon G, Harmey J, Dedrick R, Redmond PH, Bouchier-Hayes DJ. Related Articles, Links The anti-endotoxin agent, rBPI21, significantly attenuates surgically induced tumour growth in an experimental metatases murine model of breast cancer. J Surg Res. 2003 Oct;114(2):300. PMID: 14559642 [PubMed - in process] 2: O'Donoghue GT, Roche-Nagle G, Harmey JH, Bouchier-Hayes DJ. Related Articles, Links Cyclooxygenase-2 inhibition attenuates surgically induced residual tumour growth and metatases following cytoreductive surgery in a murine model of breast cancer. J Surg Res. 2003 Oct;114(2):277-8. PMID: 14559570 [PubMed - in process] 3: O'Donoghue GT, Roche-Nagle G, Connolly EM, Harmey J, Bouchier-Hayes DJ. Related Articles, Links Selective Cox-2 inhibition attenuates the perioperative increase of the tumour enhancing pro-angiogenic cytokine Vegf in human breast cancer patients. J Surg Res. 2003 Oct;114(2):243. PMID: 14559462 [PubMed - in process]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next